Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

Neurology

Volumn 79, Issue 12, 2012, Pages 1273-1277

  Kitley, Joanna ^a   Woodhall, Mark ^a   Waters, Patrick ^a   Leite, M Isabel ^a   Devenney, Emma ^b   Craig, John ^b   Palace, Jacqueline ^a   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; DEXAMETHASONE; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PREDNISOLONE; PROTEIN ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; OPTIC DISK; PARESTHESIA; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SERODIAGNOSIS; URINARY URGENCY; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84865319879     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826aac4e     Document Type: Article

References (17)

1. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477.
2. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006;59: 566-569.
3. Devic E. Myelitis subaigue compliquee de nevrite optique. Bull Med 1894;8:1033-1034.
4. Akman-Demir G, Tüzün E, Waters P, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 2011;258:464-470.
5. Bichuetti D, Oliveira E, Souza N, et al. Neuromyelitis optica in Brazil: A study on clinical and prognostic factors. Mult Scler 2009;15:613-619.
6. Collongues N, Marignier R, Zephir H, et al. Neuromyelitis optica in France: A multicenter study of 125 patients. Neurology 2010;74:736-742.
7. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-919.
8. Leite MI, Jacob S, Viegas S, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008;131:1940-1952.
9. O'Connor KC, McLaughlin KA, De Jager PL, et al. Selfantigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007;13: 211-217.
10. Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 2009;66:833-842.
11. McLaughlin KA, Chitnis T, Newcombe J, et al. Agedependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol 2009;183: 4067-4076.
12. Di Pauli F, Mader S, Rostasy K, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 2011;138:247-254.
13. Pröbstel AK, Dornmair K, Bittner R, et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011;77:580-588.
14. Wingerchuk D, Hogancamp W, O'Brien P, Weinshenker B. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
15. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch- Hagenlocher B. Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients. Neurology 2001;56: 1313-1318.
16. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011;8:184.
17. Adelmann M, Wood J, Benzel I, et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995;63:17-27.